BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37400463)

  • 21. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
    Chen W; Chen X; Li S; Ren B
    J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma.
    Tang H; You T; Sun Z; Bai C
    BMC Cancer; 2022 Feb; 22(1):197. PubMed ID: 35189839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
    Lin T; Lin Z; Mai P; Zhang E; Peng L
    Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of chloride intracellular channels as prognostic factors correlated with immune infiltration in hepatocellular carcinoma using bioinformatics analysis.
    Huang JJ; Lin J; Chen X; Zhu W
    Medicine (Baltimore); 2021 Nov; 100(45):e27739. PubMed ID: 34766585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Shi T; Morishita A; Kobara H; Masaki T
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma.
    Li H; Gao L; Kang X; Wang X; Yu Y; Zhang Y; Chen H
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker.
    Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X
    Front Oncol; 2021; 11():680070. PubMed ID: 34249720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Dis Markers; 2022; 2022():2676114. PubMed ID: 35465267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma.
    Yin T; Zhao L; Yao S
    BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-Regulation of SLC26A6 in Hepatocellular Carcinoma and Its Diagnostic and Prognostic Significance.
    Zhu Y; Huang Y; Chen L; Guo L; Wang L; Li M; Liang Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(5):79-94. PubMed ID: 34591393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N
    Peng H; Chen B; Wei W; Guo S; Han H; Yang C; Ma J; Wang L; Peng S; Kuang M; Lin S
    Nat Metab; 2022 Aug; 4(8):1041-1054. PubMed ID: 35999469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
    Yang L; He Y; Zhang Z; Wang W
    Biomed Res Int; 2020; 2020():4139320. PubMed ID: 32337246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma.
    Li Y; Mo H; Jia S; Wang J; Ma Y; Liu X; Tu K
    Front Immunol; 2022; 13():1066773. PubMed ID: 36582227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coiled-Coil Domain-Containing Protein 45 Is a Potential Prognostic Biomarker and Is Associated with Immune Cell Enrichment of Hepatocellular Carcinoma.
    Liu S; Jia L; Quan B; Rong G; Li M; Xie R; Cai Y; Bi Y; Han S
    Dis Markers; 2022; 2022():7745315. PubMed ID: 36618966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma.
    Liu H; Jia S; Guo K; Li R
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35771229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Wu M; Jiang L
    Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
    Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Front Immunol; 2022; 13():831101. PubMed ID: 35371079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.